DRCT vs REVB

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 04, 2026

DRCT

40.3
AI Score
VS
DRCT Wins

REVB

37.9
AI Score

Investment Advisor Scores

DRCT

40score
Recommendation
HOLD

REVB

38score
Recommendation
AVOID NEW MONEY

AI Analyst Insights

Detailed Metrics Comparison

Metric DRCT REVB Winner
Forward P/E 5.1125 0.8875 REVB
PEG Ratio 0 0 Tie
Revenue Growth -22.8% 0.0% REVB
Earnings Growth 302.2% 0.0% DRCT
Tradestie Score 40.3/100 37.9/100 DRCT
Profit Margin -74.4% 0.0% REVB
Beta 1.00 1.00 Tie
AI Recommendation HOLD AVOID NEW MONEY DRCT

Relative Price Performance (Last 90 Days)

DRCT 1M: -52.4% · 3M: -67.0% REVB 1M: -23.6% · 3M: -25.1%

Current Technical Phase

DRCT

Markdown
Sell / avoid

Price below a falling SMA50 (slope -15.4%), weak momentum, RSI 18

RSI (14): 17.9 · Price: $0.91

REVB

Markdown
Sell / avoid

Price below a falling SMA50 (slope -5.0%), weak momentum, RSI 26

RSI (14): 26.2 · Price: $0.76

Fundamentals Snapshot

Metric DRCT REVB
Market Cap — —
Forward P/E -0.1 -0.3
Trailing P/E — 0.0
Revenue (TTM) — —
Revenue Growth -0.2% 0.0%
Gross Margin 0.3% —
Operating Margin -0.4% 0.0%
EPS -197.09 27.03
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, DRCT is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.